BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15842936)

  • 1. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
    Ouyang T; Li JF; Wang TF; Lin BY
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
    Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
    Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dissection of the axilla in modified radical mastectomy.
    Cáceres E; Lingan M; Delgado P
    Surg Gynecol Obstet; 1976 Sep; 143(3):395-7. PubMed ID: 959960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radicality effect of adding an interpectoral to a subpectoral approach for dissection of level III axillary lymph nodes in breast cancer.
    Barros AC; Andrade FE; Bevilacqua JL; Barros MA; Piato JR; Santos DR; Filassi JR; Nimir CC
    Tumori; 2013; 99(4):500-4. PubMed ID: 24471202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A role of interpectoral (Rotter's) lymph node dissection in modified radical mastectomy for breast cancer].
    Yamasaki N; Kodama H
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1427-32. PubMed ID: 1448050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
    Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
    Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node status of T1 primary breast cancer in a diverse population.
    Madan AK; Macareo L; Winfrey K; Beech DJ
    Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node dissection: does it have a role in primary breast cancer?
    Pack MS; Thomas RS
    Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The extent of radical axillary lymph node excision].
    Müller A; Mattfeld T; Engel K; Schmidt W; Bastert G
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):524-7. PubMed ID: 2391018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed.
    Boileau JF; Easson A; Escallon JM; Leong WL; Reedijk M; Youngson BJ; McCready DR
    Ann Surg Oncol; 2008 Jun; 15(6):1710-6. PubMed ID: 18324442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
    Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
    Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Axillary lymph node dissection in clinically node-positive breast cancer].
    Iwata H; Miura S
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):831-4. PubMed ID: 12478861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
    Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
    Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of one positive axillary node.
    Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC
    Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.